These mechanisms are described as research areas, not clinical outcomes
In research catalogue terms, BPC-157 sits most naturally beside TB-500 10mg
Patients should review the medications approved indications, safety information, and potential effects with a licensed healthcare professional before starting therapy
Mechanism of action in the mouth (oral cavity) Wound healing: Stimulates fibroblast activity, collagen synthesis, and keratinocyte migration, accelerating soft tissue repair (important for periodontal disease, oral ulcers, or mucosal trauma) 2 Anti-inflammatory modulation Reduces neutrophil and macrophage overactivation, limiting collateral damage to gum tissue 3 : Bone and ligament support: Early studies suggest BPC-157 promotes tendon-to-bone healing and osteogenesis, potentially relevant for periodontitis-related bone loss or implant integration
GnRH agonists like leuprolide create a temporary menopause state, reducing pain in 85-90% of patients within 3 months, but bone loss limits use to 6-12 months without add-back therapy